Sanofi is acquiring Inhibrx to get its hands on a drug candidate in pivotal testing for the protein deficiency alpha-1 antitrypsin deficiency, which leads to lung and liver problems. Inhibrx’s remaining assets will be spun out into a new company.
The value of mergers and acquisitions (M&A) activity in the life sciences sector in Ireland rose to €1.5bn last year, a jump of 596pc compared with 2022.
Value of M&A in Irish life sciences hit €1.5bn in 2023 rte.ie - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rte.ie Daily Mail and Mail on Sunday newspapers.